Jane Street’s InspireMD NSPR Stock Holding History

Jane Street’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,743	Closed	-$12.7K	–	9644
2022 Q4	$12.7K	Buy	+14,743	New	+$16.6K	﹤0.01%	8712
2021 Q2	–	Sell	-7,467	Closed	-$75K	–	10203
2021 Q1	$75K	Buy	+7,467	New	+$88.9K	﹤0.01%	8732
2018 Q2	–	Sell	-29	Closed	-$23K	–	5402
2018 Q1	$23K	Buy	+29	New	+$99.9K	﹤0.01%	4711

Other funds holding NSPR

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BAM

Bellevue Asset Management Bellevue, Washington $200M AUM 16.19% 1-Year Est. Return

Financial Perspectives Minneapolis, Minnesota $358M AUM 22.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Jane Street's NSPR Position: Q1 2023 in Review

Jane Street sold out of InspireMD (NSPR) in Q1 2023, closing a stake of 14,743 shares — an estimated $12.7K sold.

Jane Street first reported a position in NSPR in Q1 2018 and held it in 3 quarters. The position peaked at $75K in Q1 2021. 15 funds tracked by Wall St. Rank hold NSPR as of Q1 2023.

Jane Street reported no remaining InspireMD position as of Q1 2023 after selling out during the quarter.
Jane Street sold 14,743 InspireMD shares in Q1 2023, an estimated $12.7K.
Jane Street first reported a position in InspireMD in Q1 2018 and held it in 3 quarters.
Jane Street's InspireMD position peaked at $75K in Q1 2021.
15 funds tracked by Wall St. Rank held InspireMD as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.